Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients

SUMMARY: Outcomes for melanoma patients with stage III disease differ widely even within the same subcategory. Molecular signatures that more accurately predict prognosis are needed to stratify patients according to risk. Proteomic analyses were used to identify differentially abundant proteins in e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pigment Cell Melanoma Res
Main Authors: Mactier, Swetlana, Kaufman, Kimberley L, Wang, Penghao, Crossett, Ben, Pupo, Gulietta M, Kohnke, Philippa L, Thompson, John F, Scolyer, Richard A, Yang, Jean Y, Mann, Graham J, Christopherson, Richard I
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2014
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4285183/
https://ncbi.nlm.nih.gov/pubmed/24995518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pcmr.12290
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados